1. Home
  2. PRQR vs TMQ Comparison

PRQR vs TMQ Comparison

Compare PRQR & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRQR
  • TMQ
  • Stock Information
  • Founded
  • PRQR 2012
  • TMQ 2004
  • Country
  • PRQR Netherlands
  • TMQ Canada
  • Employees
  • PRQR N/A
  • TMQ N/A
  • Industry
  • PRQR Biotechnology: Pharmaceutical Preparations
  • TMQ Precious Metals
  • Sector
  • PRQR Health Care
  • TMQ Basic Materials
  • Exchange
  • PRQR Nasdaq
  • TMQ Nasdaq
  • Market Cap
  • PRQR 179.1M
  • TMQ 211.9M
  • IPO Year
  • PRQR 2014
  • TMQ N/A
  • Fundamental
  • Price
  • PRQR $1.94
  • TMQ $1.27
  • Analyst Decision
  • PRQR Strong Buy
  • TMQ
  • Analyst Count
  • PRQR 7
  • TMQ 0
  • Target Price
  • PRQR $9.00
  • TMQ N/A
  • AVG Volume (30 Days)
  • PRQR 302.0K
  • TMQ 711.0K
  • Earning Date
  • PRQR 08-07-2025
  • TMQ 07-09-2025
  • Dividend Yield
  • PRQR N/A
  • TMQ N/A
  • EPS Growth
  • PRQR N/A
  • TMQ N/A
  • EPS
  • PRQR N/A
  • TMQ N/A
  • Revenue
  • PRQR $21,212,711.00
  • TMQ N/A
  • Revenue This Year
  • PRQR $2.87
  • TMQ N/A
  • Revenue Next Year
  • PRQR N/A
  • TMQ N/A
  • P/E Ratio
  • PRQR N/A
  • TMQ N/A
  • Revenue Growth
  • PRQR 85.91
  • TMQ N/A
  • 52 Week Low
  • PRQR $1.07
  • TMQ $0.42
  • 52 Week High
  • PRQR $4.62
  • TMQ $2.09
  • Technical
  • Relative Strength Index (RSI)
  • PRQR 63.06
  • TMQ 43.14
  • Support Level
  • PRQR $1.77
  • TMQ $1.27
  • Resistance Level
  • PRQR $1.96
  • TMQ $1.37
  • Average True Range (ATR)
  • PRQR 0.10
  • TMQ 0.07
  • MACD
  • PRQR 0.01
  • TMQ 0.01
  • Stochastic Oscillator
  • PRQR 80.78
  • TMQ 47.50

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

About TMQ Trilogy Metals Inc.

Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.

Share on Social Networks: